T1	CHEM 98 104	LCZ696
#1	AnnotatorNotes T1	C2933615; LCZ 696; Organic Chemical
T2	PROC 82 93	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 156 178	insuficiencia cardíaca
#3	AnnotatorNotes T3	C0018801; Heart failure; Disease or Syndrome
T4	DISO 183 212	fracción de eyección reducida
T5	DISO 242 263	descompensación aguda
T6	PROC 286 351	Estudio multicéntrico, aleatorizado, abierto, de grupos paralelos
T7	PROC 387 398	tratamiento
#4	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	DISO 461 483	insuficiencia cardíaca
#5	AnnotatorNotes T8	C0018801; Heart failure; Disease or Syndrome
T9	DISO 488 517	fracción de eyección reducida
T10	CHEM 403 409	LCZ696
#6	AnnotatorNotes T10	C2933615; LCZ 696; Organic Chemical
T11	PROC 518 532	hospitalizados
#7	AnnotatorNotes T11	C0019993; Hospitalization; Health Care Activity
T12	DISO 557 578	descompensación aguda
T13	DISO 630 652	Insuficiencia cardíaca
#8	AnnotatorNotes T13	C0018801; Heart failure; Disease or Syndrome
T14	DISO 679 701	Insuficiencia cardíaca
#9	AnnotatorNotes T14	C0018801; Heart failure; Disease or Syndrome
T15	DISO 706 735	fracción de eyección reducida
T16	PROC 772 787	hospitalización
#10	AnnotatorNotes T16	C0019993; Hospitalization; Health Care Activity
T17	DISO 808 829	descompensación aguda
T18	PROC 869 883	hospitalizados
#11	AnnotatorNotes T18	C0019993; Hospitalization; Health Care Activity
T19	DISO 908 929	descompensación aguda
T20	DISO 936 958	insuficiencia cardiaca
#12	AnnotatorNotes T20	C0018801; Heart failure; Disease or Syndrome
T21	PROC 968 979	Diagnóstico
#13	AnnotatorNotes T21	C0011900; Diagnosis; Diagnostic Procedure
T22	DISO 1035 1064	fracción de eyección reducida
T23	PROC 1725 1729	MDRD
#14	AnnotatorNotes T23	C1980036; Creatinine-based formula (MDRD); Laboratory Procedure
T24	CHEM 1106 1119	vasodilatador
#15	AnnotatorNotes T24	C0042402; Vasodilator Agents; Pharmacologic Substance
T26	PROC 1157 1175	terapia inotrópica
T27	PROC 1240 1254	Aleatorización
#16	AnnotatorNotes T27	C0034656; Randomization; Research Activity
T28	PROC 1336 1350	Aleatorización
#17	AnnotatorNotes T28	C0034656; Randomization; Research Activity
T29	PROC 1416 1425	protocolo
#18	AnnotatorNotes T29	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T30	DISO 1455 1478	Hipotensión sintomática
#19	AnnotatorNotes T30	C0863113; Hypotension symptomatic; Pathologic Function
T31	PROC 1527 1541	aleatorización
#20	AnnotatorNotes T31	C0034656; Randomization; Research Activity
T32	DISO 1544 1560	Enfermedad renal
#21	AnnotatorNotes T32	C0022658; Kidney Diseases; Disease or Syndrome
T33	PROC 1597 1609	TFG estimada
#22	AnnotatorNotes T33	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T34	DISO 1707 1723	enfermedad renal
#23	AnnotatorNotes T34	C0022658; Kidney Diseases; Disease or Syndrome
T35	PROC 1737 1751	aleatorización
#24	AnnotatorNotes T35	C0034656; Randomization; Research Activity
T36	CHEM 1755 1762	Potasio
#25	AnnotatorNotes T36	C0032821; potassium; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T37	ANAT 1763 1769	sérico
#26	AnnotatorNotes T37	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T38	PROC 1789 1803	aleatorización
#27	AnnotatorNotes T38	C0034656; Randomization; Research Activity
T39	DISO 1833 1868	angioedema hereditario o idiopático
T40	DISO 1871 1881	angioedema
#28	AnnotatorNotes T40	C0002994; Angioedema; Pathologic Function
T41	PROC 1898 1905	terapia
#29	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	CHEM 1917 1921	IECA
#30	AnnotatorNotes T42	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T43	DISO 1932 1954	Insuficiencia hepática
#31	AnnotatorNotes T43	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T44	DISO 1962 1977	cirrosis biliar
#32	AnnotatorNotes T44	C0023892; Biliary cirrhosis; Disease or Syndrome
T45	DISO 1980 1990	colestasis
#33	AnnotatorNotes T45	C0008370; Cholestasis; Disease or Syndrome
T46	PROC 2056 2065	protocolo
#34	AnnotatorNotes T46	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T47	ANAT 170 178	cardíaca
#35	AnnotatorNotes T47	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T48	ANAT 475 483	cardíaca
#36	AnnotatorNotes T48	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T49	ANAT 644 652	cardíaca
#37	AnnotatorNotes T49	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T50	ANAT 693 701	cardíaca
#38	AnnotatorNotes T50	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T51	ANAT 950 958	cardiaca
#39	AnnotatorNotes T51	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T52	DISO 983 985	IC
#40	AnnotatorNotes T52	C0018801; Heart failure; Disease or Syndrome
T53	PROC 1483 1486	PAS
#41	AnnotatorNotes T53	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T54	PROC 1500 1503	PAS
#42	AnnotatorNotes T54	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T55	ANAT 1555 1560	renal
#43	AnnotatorNotes T55	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T56	PROC 1649 1700	fórmula de la modificación simplificada de la dieta
T57	ANAT 1718 1723	renal
#44	AnnotatorNotes T57	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T58	PROC 1755 1769	Potasio sérico
#45	AnnotatorNotes T58	C0302353; Serum potassium measurement; Laboratory Procedure
T59	CHEM 1924 1929	ARAII
#46	AnnotatorNotes T59	C0521942; Angiotensin II receptor antagonist; Pharmacologic Substance
T60	ANAT 1946 1954	hepática
#47	AnnotatorNotes T60	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T61	ANAT 1971 1977	biliar
#48	AnnotatorNotes T61	C0005388; Bile fluid; Body Substance
T62	Date 13 17	2015
T63	LIVB 142 151	pacientes
#49	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	LIVB 447 456	pacientes
#50	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	LIVB 859 868	Pacientes
#51	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	PROC 1006 1032	New York Heart Association
#52	AnnotatorNotes T66	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T67	LIVB 1067 1076	Pacientes
#53	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T69	Neg_cue 1099 1105	ningún
T70	Route 1120 1124	i.v.
#54	AnnotatorNotes T70	C1522726; Intravenous Route of Drug Administration; Functional Concept
T71	CHEM 1134 1142	nitratos
#55	AnnotatorNotes T71	C0028125; Nitrates; Chemical Viewed Structurally
T72	Neg_cue 1149 1156	ninguna
T73	Route 1176 1180	i.v.
#56	AnnotatorNotes T73	C1522726; Intravenous Route of Drug Administration; Functional Concept
T74	Duration 1309 1326	al menos 24 horas
T79	PHYS 183 203	fracción de eyección
#57	AnnotatorNotes T79	C0232174; Cardiac ejection fraction; Organ or Tissue Function
T80	PHYS 488 508	fracción de eyección
#58	AnnotatorNotes T80	C0232174; Cardiac ejection fraction; Organ or Tissue Function
T81	PHYS 706 726	fracción de eyección
#59	AnnotatorNotes T81	C0232174; Cardiac ejection fraction; Organ or Tissue Function
T82	PHYS 1035 1055	fracción de eyección
#60	AnnotatorNotes T82	C0232174; Cardiac ejection fraction; Organ or Tissue Function
T25	PROC 115 119	alta
#61	AnnotatorNotes T25	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
T68	PROC 134 138	alta
#62	AnnotatorNotes T68	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
T75	PROC 439 443	alta
#63	AnnotatorNotes T75	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
T76	PROC 420 424	alta
#64	AnnotatorNotes T76	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
A1	Assertion T24 Negated
A2	Assertion T26 Negated
A3	Status T24 History_of
A4	Status T71 History_of
A5	Status T26 History_of
A6	Status T39 History_of
A7	Status T40 History_of
A8	Status T41 History_of
A9	Status T42 History_of
A10	Status T59 History_of
#65	AnnotatorNotes T6	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C1709323; Open Label Study; Research Activity + C2826345; Parallel Study; Research Activity 
#66	AnnotatorNotes T4	C4022792; Reduced ejection fraction; Finding  
#67	AnnotatorNotes T9	C4022792; Reduced ejection fraction; Finding
#68	AnnotatorNotes T15	C4022792; Reduced ejection fraction; Finding
#69	AnnotatorNotes T22	C4022792; Reduced ejection fraction; Finding
#70	AnnotatorNotes T39	C1304177; Idiopathic angioedema; Disease or Syndrome + C0019243; Angioedemas, Hereditary; Disease or Syndrome 
A11	Assertion T70 Negated
A12	Assertion T73 Negated
T77	Spec_cue 1353 1362	Se pueden
T78	Quantifier_or_Qualifier 1371 1376	otros
A13	Assertion T78 Speculated
T83	CONC 1377 1399	criterios de inclusión
A14	Assertion T83 Speculated
#71	AnnotatorNotes T83	C1512693; Inclusion Criteria; Qualitative Concept
R1	Has_Quantifier_or_Qualifier Arg1:T83 Arg2:T78	
R2	Speculation Arg1:T77 Arg2:T78	
R3	Speculation Arg1:T77 Arg2:T83	
T84	Spec_cue 1993 2002	Se pueden
T85	Quantifier_or_Qualifier 2011 2016	otros
A15	Assertion T85 Speculated
T86	CONC 2017 2039	criterios de exclusión
A16	Assertion T86 Speculated
#72	AnnotatorNotes T86	C0680251; Exclusion Criteria; Functional Concept
R4	Has_Quantifier_or_Qualifier Arg1:T86 Arg2:T85	
R5	Speculation Arg1:T84 Arg2:T85	
R6	Speculation Arg1:T84 Arg2:T86	
R9	Negation Arg1:T69 Arg2:T24	
R10	Negation Arg1:T69 Arg2:T70	
R11	Negation Arg1:T72 Arg2:T26	
R12	Negation Arg1:T72 Arg2:T73	
T87	Result_or_Value 1504 1514	> 180 mmHg
R13	Has_Result_or_Value Arg1:T54 Arg2:T87	
T88	Result_or_Value 1487 1497	< 110 mmHg
R14	Has_Result_or_Value Arg1:T53 Arg2:T88	
R15	Before Arg1:T53 Arg2:T31	
R16	Before Arg1:T30 Arg2:T31	
R17	Before Arg1:T54 Arg2:T31	
R18	Location_of Arg1:T55 Arg2:T32	
T89	Result_or_Value 1610 1629	< 30 mL/min/1,73 m2
R20	Has_Result_or_Value Arg1:T33 Arg2:T89	
#73	AnnotatorNotes T56	C1980036; Creatinine-based formula (MDRD); Laboratory Procedure
R21	Location_of Arg1:T57 Arg2:T34	
R23	Overlap Arg1:T23 Arg2:T35	
R24	Overlap Arg1:T34 Arg2:T35	
R25	Overlap Arg1:T56 Arg2:T35	
R26	Overlap Arg1:T33 Arg2:T35	
R27	Overlap Arg1:T32 Arg2:T35	
T90	Quantifier_or_Qualifier 1564 1577	fase terminal
R28	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T90	
R30	Used_for Arg1:T1 Arg2:T2	
T91	CONC 71 93	inicio del tratamiento
R29	Before Arg1:T91 Arg2:T25	
R31	After Arg1:T91 Arg2:T68	
R32	Experiences Arg1:T63 Arg2:T2	
R33	Experiences Arg1:T63 Arg2:T3	
R34	Location_of Arg1:T47 Arg2:T3	
R35	Overlap Arg1:T3 Arg2:T4	
R37	Experiences Arg1:T63 Arg2:T79	
R38	After Arg1:T4 Arg2:T5	
T92	CONC 376 398	inicio del tratamiento
R39	Used_for Arg1:T10 Arg2:T7	
R40	Before Arg1:T92 Arg2:T76	
R41	After Arg1:T92 Arg2:T75	
R42	Experiences Arg1:T64 Arg2:T7	
R43	Experiences Arg1:T64 Arg2:T8	
R44	Location_of Arg1:T48 Arg2:T8	
R45	Overlap Arg1:T8 Arg2:T9	
R46	Causes Arg1:T12 Arg2:T9	
R47	Experiences Arg1:T64 Arg2:T9	
R48	Experiences Arg1:T64 Arg2:T80	
R49	Experiences Arg1:T64 Arg2:T11	
R50	Experiences Arg1:T64 Arg2:T12	
R51	Location_of Arg1:T49 Arg2:T13	
R56	Location_of Arg1:T50 Arg2:T14	
R57	Overlap Arg1:T14 Arg2:T15	
T93	Observation 745 757	estabilizada
#74	AnnotatorNotes T93	C0184512; Stabilized (qualifier value); Finding
R59	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T93	
R60	After Arg1:T93 Arg2:T16	
R61	After Arg1:T15 Arg2:T17	
R63	Overlap Arg1:T14 Arg2:T93	
R64	Overlap Arg1:T15 Arg2:T93	
R65	Experiences Arg1:T65 Arg2:T18	
R66	Overlap Arg1:T19 Arg2:T20	
R67	Location_of Arg1:T51 Arg2:T20	
R68	Experiences Arg1:T65 Arg2:T19	
R69	Experiences Arg1:T65 Arg2:T20	
T94	Result_or_Value 986 999	clase II a IV
R70	Has_Result_or_Value Arg1:T66 Arg2:T94	
R72	Overlap Arg1:T18 Arg2:T19	
R73	Overlap Arg1:T18 Arg2:T20	
R74	Overlap Arg1:T52 Arg2:T22	
R76	Experiences Arg1:T67 Arg2:T24	
R77	Has_Route_or_Mode Arg1:T24 Arg2:T70	
R78	Experiences Arg1:T67 Arg2:T71	
R79	Experiences Arg1:T67 Arg2:T26	
R81	Before Arg1:T26 Arg2:T27	
R82	Before Arg1:T24 Arg2:T27	
R83	Before Arg1:T71 Arg2:T27	
T95	Observation 1257 1269	Estabilizado
#75	AnnotatorNotes T95	C0184512; Stabilized (qualifier value); Finding
R84	Has_Duration_or_Interval Arg1:T95 Arg2:T74	
T96	Observation 1280 1299	está en el hospital
#76	AnnotatorNotes T96	C0701159; Patient in hospital (finding); Finding
R85	Overlap Arg1:T95 Arg2:T96	
R86	Before Arg1:T95 Arg2:T28	
R87	Location_of Arg1:T37 Arg2:T58	
T97	Result_or_Value 1770 1782	> 5,4 mmol/L
R88	Has_Result_or_Value Arg1:T58 Arg2:T97	
R89	Overlap Arg1:T58 Arg2:T38	
R90	Causes Arg1:T41 Arg2:T40	
R91	Causes Arg1:T41 Arg2:T39	
R92	Used_for Arg1:T42 Arg2:T41	
R93	Location_of Arg1:T60 Arg2:T43	
R94	Location_of Arg1:T61 Arg2:T44	
T98	Quantifier_or_Qualifier 1955 1960	grave
#77	AnnotatorNotes T98	C1547227; Severe - Severity of Illness Code; Intellectual Product
R95	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T98	
R96	Experiences Arg1:T63 Arg2:T5	
T99	PROC 1584 1593	Selección
#78	AnnotatorNotes T99	C0242802; Patient Selection; Research Activity
R97	Overlap Arg1:T32 Arg2:T99	
#79	AnnotatorNotes T78	C0205394; Other; Qualitative Concept
R19	Used_for Arg1:T59 Arg2:T41	
#80	AnnotatorNotes T85	C0205394; Other; Qualitative Concept
#81	AnnotatorNotes T90	C0205088; End-stage; Qualitative Concept
T100	CHEM 1165 1175	inotrópica
#82	AnnotatorNotes T100	C5147552; Inotropic support; Pharmacologic Substance
R7	Used_for Arg1:T100 Arg2:T26	
A17	Assertion T100 Negated
R8	Has_Route_or_Mode Arg1:T100 Arg2:T73	
R22	Negation Arg1:T72 Arg2:T100	
A18	Experiencer T63 Patient
A19	Experiencer T64 Patient
A20	Experiencer T65 Patient
A21	Experiencer T67 Patient
